0001288469-23-000158.txt : 20230822
0001288469-23-000158.hdr.sgml : 20230822
20230822183005
ACCESSION NUMBER: 0001288469-23-000158
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230820
FILED AS OF DATE: 20230822
DATE AS OF CHANGE: 20230822
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LITCHFIELD STEVEN G
CENTRAL INDEX KEY: 0001286030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34666
FILM NUMBER: 231194774
MAIL ADDRESS:
STREET 1: C/O MAXLINEAR, INC.
STREET 2: 5966 LA PLACE COURT, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAXLINEAR, INC
CENTRAL INDEX KEY: 0001288469
STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674]
IRS NUMBER: 141896129
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5966 LA PLACE CT.
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 760-692-0711
MAIL ADDRESS:
STREET 1: 5966 LA PLACE CT.
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER COMPANY:
FORMER CONFORMED NAME: MAXLINEAR INC
DATE OF NAME CHANGE: 20040423
4
1
wk-form4_1692743396.xml
FORM 4
X0508
4
2023-08-20
0
0001288469
MAXLINEAR, INC
MXL
0001286030
LITCHFIELD STEVEN G
C/O MAXLINEAR, INC.
5966 LA PLACE COURT, SUITE 100
CARLSBAD
CA
92008
0
1
0
0
See remarks
0
Common Stock
2023-08-20
4
A
0
1260
0
A
363338
D
Common Stock
2023-08-20
4
A
0
1655
0
A
364993
D
Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the performance period ended July 2023 that were approved as part of the 2022 performance-based restricted stock award granted on July 29, 2022. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. The Reporting Person has deferred settlement of the shares pursuant to a Performance-Based Restricted Stock Unit Election Form entered into by the Reporting Person on September 15, 2022 until the earliest of (i) the date of termination of the executive officer's service to the Company; or (ii) a qualifying change in control.
Chief Financial Officer and Chief Corporate Strategy Officer
/s/ Connie Kwong, as Attorney-in-Fact
2023-08-22